SOJ Biochemistry Open Access Research article cancer chemotherapeutic drugs, which acts on the specific phase of the cell cycle, especially the S phase of cell division [2]. The doxorubicin has been introduced in the clinics to treat various malignant diseases in the early 1970s and remains an integral part of various modern chemotherapeutic regimens where it is used to treat different malignant neoplasia including Hodgkin's and non-Hodgkin's lymphomas, myeloblastic leukemias, breast cancer, small cell lung cancer, ovarian cancer, childhood solid tumors, hepatocarcinomas, soft tissue sarcomas, Kaposi's sarcoma, and bone tumors [3-7].